To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis.
Actinic Keratosis
DRUG: Ingenol Mebutate (Perrigo)|DRUG: Ingenol Mebutate (Reference)|DRUG: Placebo gel
Number of Participants With Complete Clearance (Absence) of Actinic Keratosis Lesions, Baseline to Day 57
The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis.